Medication adherence: Hope for improvement?

Mayo Clinic Proceedings

Volumn 86, Issue 4, 2011, Pages 268-270

  Epstein, Robert S ^a  

^a Medco Health Solutions   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; PLACEBO; PRAVASTATIN; SIMVASTATIN; STATIN; WARFARIN;

CARDIOVASCULAR DISEASE; DRUG EFFICACY; DRUG MONITORING; EDITORIAL; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEART INFARCTION; HUMAN; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHARMACOGENOMICS; PHARMACY;

EID: 79953294161     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2011.0123     Document Type: Editorial

References (11)

1. Dunlay SM, Eveleth JM, Shah ND, McNallan SM, Roger VL. Medication adherence among community-dwelling patients with heart failure. Mayo Clin Proc. 2011;86(4):273-281.
2. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304-314.
3. Thinking outside the pillbox: a system-wide approach to improving patient medication adherence for chronic disease. New England Healthcare Institute Web site. http://www.nehi.net/publications/44/thinking-outside-the-pillbox-a- systemwide-approach-to-improving-patient-medication-adherence- for-chronic-disease. Accessed February 28, 2011.
4. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344(8934):1383-1389.
5. Omnibus Budget Reconciliation Act. Public Law No. 101-508, 104 Stat 1388 enacted 5 November 1990.
6. Electronic prescribing (eRx) incentive program. Centers for Medicare & Medicaid Services (CMS) Web site. https://www.cms.gov/ERXIncentive/. Accessed February 28, 2011.
7. Epstein RS, Moyer TP, Aubert RE, et al. Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness Study). J Am Coll Cardiol. 2010;55(25):2804-2812.
8. Iakoubova OA, Sabatine MS, Rowland CM, et al. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. J Am Coll Cardiol. 2008;51:449-455.
9. Iakoubova OA, Tong CH, Rowland CM, et al. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. J Am Coll Cardiol. 2008;51:435-443.
10. Iakoubova OA, Robertson M, Tong CH, et al. KIF6 Trp719Arg polymorphism and effect of statin therapy in elderly patients: results from the PROSPER study. Eur J Cardiovasc Prev Rehabil. 2010;17(4):455-461.
11. Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS). Clinical Trials.gov Web site. http://www.clinicaltrials.gov/ct2/show/ NCT01068834?term=akrobats&rank=1. Accessed February 28, 2011.